This is educational information, not medical advice, and The Peptide University does not sell peptides, supplies, or supplements. Many compounds discussed here are sold as “research chemicals” and are not approved for human use outside of clinical trials. Laws vary by country, and nothing here is a recommendation to obtain or use anything. Talk to a qualified clinician about your own situation.
KPV is a tripeptide fragment (lysine-proline-valine) derived from the C-terminus of alpha-melanocyte-stimulating hormone (alpha-MSH). It's experimental, with no approved human use.
How it works
It carries alpha-MSH's anti-inflammatory activity without the pigmentation effects of the full hormone, appearing to dampen inflammatory signaling inside cells — studied especially in gut inflammation models.
The evidence
Evidence is largely preclinical (cell and animal models of inflammation, including colitis). Human clinical data is limited, so its real-world benefit and dosing are unproven.
Safety
As a mostly-preclinical compound, human safety isn't well characterized. It's an unapproved research chemical; both effects and vial contents are open questions.
FAQ
QIs it related to melanotan?
Both derive from alpha-MSH, but KPV is a small fragment aimed at anti-inflammatory effects, without the tanning/central actions.
QIs there human proof?
Limited — most evidence is preclinical.
Sources
This profile summarizes the following. Follow the links to read the originals — and remember that summaries age, so check for newer information.
Inclusion here is not endorsement of any source's claims; several are cited so you can compare how different outlets characterize the same evidence.
Questions & comments
No account, no login — leave a name or stay anonymous. Ask a question, add something the article missed, or answer someone else. Be kind and cite sources where you can.